<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9225138</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">35743669</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">9225138</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.3390/jpm12060884</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="publisher-id">jpm-12-00884</article-id></all-ids><extracted-table><table-id>jpm-12-00884-t001</table-id><table-label>Table 1</table-label><table-caption>Demographic and clinical characteristics of all subjects.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="jpm-12-00884-t001"><object-id pub-id-type="pii">jpm-12-00884-t001_Table 1</object-id><label>Table 1</label><caption><p>Demographic and clinical characteristics of all subjects.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Variables</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PDF (<italic toggle="yes">n</italic> = 16)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PDNF (<italic toggle="yes">n</italic> = 16)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HCs (<italic toggle="yes">n</italic> = 15)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> Value</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age (y) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">57.25 ± 13.98</td><td align="center" valign="middle" rowspan="1" colspan="1">63.37 ± 9.19</td><td align="center" valign="middle" rowspan="1" colspan="1">63.80 ± 5.72</td><td align="center" valign="middle" rowspan="1" colspan="1">0.147</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Sex (F/M) <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8/8</td><td align="center" valign="middle" rowspan="1" colspan="1">4/12</td><td align="center" valign="middle" rowspan="1" colspan="1">5/10</td><td align="center" valign="middle" rowspan="1" colspan="1">0.326</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Education (y) <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">11.68 ± 3.43</td><td align="center" valign="middle" rowspan="1" colspan="1">11.06 ± 4.15</td><td align="center" valign="middle" rowspan="1" colspan="1">11.33 ± 3.45</td><td align="center" valign="middle" rowspan="1" colspan="1">0.922</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">MMSE <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">28.25 ± 1.34</td><td align="center" valign="middle" rowspan="1" colspan="1">28.43 ± 1.20</td><td align="center" valign="middle" rowspan="1" colspan="1">28.93 ± 1.16</td><td align="center" valign="middle" rowspan="1" colspan="1">0.317</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Disease duration (y) <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">5.37 ± 3.52</td><td align="center" valign="middle" rowspan="1" colspan="1">6.50 ± 3.38</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">0.296</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">H&amp;Y <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2.34 ± 0.67</td><td align="center" valign="middle" rowspan="1" colspan="1">2.00 ± 0.60</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">0.130</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">UPDRS-III <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">29.00 ± 11.00</td><td align="center" valign="middle" rowspan="1" colspan="1">28.31 ± 11.72</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">0.865</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">LEDD (mg/day) <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">613.67 ± 248.89</td><td align="center" valign="middle" rowspan="1" colspan="1">659.68 ± 349.92</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">0.671</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">ESS <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">5.06 ± 3.67</td><td align="center" valign="middle" rowspan="1" colspan="1">4.06 ± 3.21</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">0.419</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AS <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">10.06 ± 2.69</td><td align="center" valign="middle" rowspan="1" colspan="1">8.31 ± 3.51</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">HAMD <sup>e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">10.38 ± 4.98</td><td align="center" valign="middle" rowspan="1" colspan="1">7.94 ± 4.16</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">0.143</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">HAMA <sup>e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">10.56 ± 4.75</td><td align="center" valign="middle" rowspan="1" colspan="1">8.44 ± 5.42</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">0.247</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">FSS/9 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">5.13 ± 1.06</td><td align="center" valign="middle" rowspan="1" colspan="1">2.07 ± 1.06</td><td align="center" valign="middle" rowspan="1" colspan="1">1.50 ± 0.42</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001 *</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Post hoc</td><td colspan="3" align="center" valign="middle" rowspan="1">PDF vs. PDNF</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001 *</td></tr><tr><td colspan="3" align="center" valign="middle" rowspan="1">PDF vs. HC</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001 *</td></tr><tr><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">PDNF vs. HC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.089</td></tr></tbody></table><table-wrap-foot><fn><p>Values are presented as the mean ± standard deviation. <sup>a</sup> One-way ANOVA test, <sup>b</sup> chi-square test, <sup>c</sup> Kruskal–Wallis test, <sup>d</sup> Mann–Whitney U test, <sup>e</sup> Student’s t test. * <italic toggle="yes">p</italic> &lt; 0.05 was considered significant. Abbreviations: HCs: healthy controls, PDF: Parkinson’s disease with fatigue, PDNF: Parkinson’s disease without fatigue, NA: not applicable, F: Female, M: Male, y: year, MMSE: Mini-Mental State Examination, H&amp;Y: Hoehn and Yahr stage, UPDRS: unified Parkinson’s disease rating scale, LEDD: levodopa equivalent daily dose, AS: apathy scale, ESS: Epworth Sleepiness Scale, HAMD: 24-item Hamilton Depression Rating Scale, HAMA: Hamilton Anxiety Rating Scale, FSS: fatigue severity scale.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>jpm-12-00884-t001_Table 1Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and clinical characteristics of all subjects.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">Variables</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">PDF (n = 16)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">PDNF (n = 16)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">HCs (n = 15)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">p Value</th></tr></thead><tbody><tr><td align="center" valign="middle">Age (y) a</td><td align="center" valign="middle">57.25 ± 13.98</td><td align="center" valign="middle">63.37 ± 9.19</td><td align="center" valign="middle">63.80 ± 5.72</td><td align="center" valign="middle">0.147</td></tr><tr><td align="center" valign="middle">Sex (F/M) b</td><td align="center" valign="middle">8/8</td><td align="center" valign="middle">4/12</td><td align="center" valign="middle">5/10</td><td align="center" valign="middle">0.326</td></tr><tr><td align="center" valign="middle">Education (y) c</td><td align="center" valign="middle">11.68 ± 3.43</td><td align="center" valign="middle">11.06 ± 4.15</td><td align="center" valign="middle">11.33 ± 3.45</td><td align="center" valign="middle">0.922</td></tr><tr><td align="center" valign="middle">MMSE c</td><td align="center" valign="middle">28.25 ± 1.34</td><td align="center" valign="middle">28.43 ± 1.20</td><td align="center" valign="middle">28.93 ± 1.16</td><td align="center" valign="middle">0.317</td></tr><tr><td align="center" valign="middle">Disease duration (y) d</td><td align="center" valign="middle">5.37 ± 3.52</td><td align="center" valign="middle">6.50 ± 3.38</td><td align="center" valign="middle">NA</td><td align="center" valign="middle">0.296</td></tr><tr><td align="center" valign="middle">H&amp;Y d</td><td align="center" valign="middle">2.34 ± 0.67</td><td align="center" valign="middle">2.00 ± 0.60</td><td align="center" valign="middle">NA</td><td align="center" valign="middle">0.130</td></tr><tr><td align="center" valign="middle">UPDRS-III d</td><td align="center" valign="middle">29.00 ± 11.00</td><td align="center" valign="middle">28.31 ± 11.72</td><td align="center" valign="middle">NA</td><td align="center" valign="middle">0.865</td></tr><tr><td align="center" valign="middle">LEDD (mg/day) d</td><td align="center" valign="middle">613.67 ± 248.89</td><td align="center" valign="middle">659.68 ± 349.92</td><td align="center" valign="middle">NA</td><td align="center" valign="middle">0.671</td></tr><tr><td align="center" valign="middle">ESS d</td><td align="center" valign="middle">5.06 ± 3.67</td><td align="center" valign="middle">4.06 ± 3.21</td><td align="center" valign="middle">NA</td><td align="center" valign="middle">0.419</td></tr><tr><td align="center" valign="middle">AS d</td><td align="center" valign="middle">10.06 ± 2.69</td><td align="center" valign="middle">8.31 ± 3.51</td><td align="center" valign="middle">NA</td><td align="center" valign="middle">0.125</td></tr><tr><td align="center" valign="middle">HAMD e</td><td align="center" valign="middle">10.38 ± 4.98</td><td align="center" valign="middle">7.94 ± 4.16</td><td align="center" valign="middle">NA</td><td align="center" valign="middle">0.143</td></tr><tr><td align="center" valign="middle">HAMA e</td><td align="center" valign="middle">10.56 ± 4.75</td><td align="center" valign="middle">8.44 ± 5.42</td><td align="center" valign="middle">NA</td><td align="center" valign="middle">0.247</td></tr><tr><td align="center" valign="middle">FSS/9 a</td><td align="center" valign="middle">5.13 ± 1.06</td><td align="center" valign="middle">2.07 ± 1.06</td><td align="center" valign="middle">1.50 ± 0.42</td><td align="center" valign="middle">&lt;0.001 *</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin">Post hoc</td><td colspan="3" align="center" valign="middle">PDF vs. PDNF</td><td align="center" valign="middle">&lt;0.001 *</td></tr><tr><td colspan="3" align="center" valign="middle">PDF vs. HC</td><td align="center" valign="middle">&lt;0.001 *</td></tr><tr><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin">PDNF vs. HC</td><td align="center" valign="middle" style="border-bottom:solid thin">0.089</td></tr></tbody></table></div>Values are presented as the mean ± standard deviation. a One-way ANOVA test, b chi-square test, c Kruskal–Wallis test, d Mann–Whitney U test, e Student’s t test. * p &lt; 0.05 was considered significant. Abbreviations: HCs: healthy controls, PDF: Parkinson’s disease with fatigue, PDNF: Parkinson’s disease without fatigue, NA: not applicable, F: Female, M: Male, y: year, MMSE: Mini-Mental State Examination, H&amp;Y: Hoehn and Yahr stage, UPDRS: unified Parkinson’s disease rating scale, LEDD: levodopa equivalent daily dose, AS: apathy scale, ESS: Epworth Sleepiness Scale, HAMD: 24-item Hamilton Depression Rating Scale, HAMA: Hamilton Anxiety Rating Scale, FSS: fatigue severity scale.</transformed-table></extracted-table><extracted-table><table-id>jpm-12-00884-t002</table-id><table-label>Table 2</table-label><table-caption>Regions showing significant differences in VMHC between groups.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="jpm-12-00884-t002"><object-id pub-id-type="pii">jpm-12-00884-t002_Table 2</object-id><label>Table 2</label><caption><p>Regions showing significant differences in VMHC between groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Brain Regions<break/>(AAL)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Number of Voxels</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">MNI Coordinates</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><italic toggle="yes">T</italic> Value</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">X</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Y</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Z</th></tr></thead><tbody><tr><td colspan="6" align="center" valign="middle" rowspan="1">PDF &gt; PDNF</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SMG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">±54</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−39</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−3.9081</td></tr><tr><td colspan="6" align="center" valign="middle" rowspan="1">PDF &gt; HCs</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">IFG operc</td><td align="center" valign="middle" rowspan="1" colspan="1">36</td><td align="center" valign="middle" rowspan="1" colspan="1">±54</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">−4.7763</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">SMG</td><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">±51</td><td align="center" valign="middle" rowspan="1" colspan="1">−42</td><td align="center" valign="middle" rowspan="1" colspan="1">36</td><td align="center" valign="middle" rowspan="1" colspan="1">−4.4129</td></tr><tr><td colspan="6" align="center" valign="middle" style="border-top:solid thin" rowspan="1">PDNF &gt; HCs</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">IFG operc</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">±54</td><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">−3.6089</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MFG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">±42</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">−3.8621</td></tr></tbody></table><table-wrap-foot><fn><p>A corrected threshold of <italic toggle="yes">p</italic> &lt; 0.01, corrected by Monte Carlo. Anatomical Automatic Labeling 90 was used to report the anatomical regions of our clusters. Abbreviations: HCs: healthy controls, PDF: Parkinson’s disease with fatigue, PDNF: Parkinson’s disease without fatigue, MNI: Montreal Neurological Institute, SMG: supramarginal gyri, IFG operc: opercular parts of inferior frontal gyri, MFG: middle frontal gyri.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>jpm-12-00884-t002_Table 2Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Regions showing significant differences in VMHC between groups.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">Brain Regions(AAL)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">Number of Voxels</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">MNI Coordinates</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">T Value</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin">X</th><th align="center" valign="middle" style="border-bottom:solid thin">Y</th><th align="center" valign="middle" style="border-bottom:solid thin">Z</th></tr></thead><tbody><tr><td colspan="6" align="center" valign="middle">PDF &gt; PDNF</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">SMG</td><td align="center" valign="middle" style="border-bottom:solid thin">15</td><td align="center" valign="middle" style="border-bottom:solid thin">±54</td><td align="center" valign="middle" style="border-bottom:solid thin">−39</td><td align="center" valign="middle" style="border-bottom:solid thin">33</td><td align="center" valign="middle" style="border-bottom:solid thin">−3.9081</td></tr><tr><td colspan="6" align="center" valign="middle">PDF &gt; HCs</td></tr><tr><td align="center" valign="middle">IFG operc</td><td align="center" valign="middle">36</td><td align="center" valign="middle">±54</td><td align="center" valign="middle">12</td><td align="center" valign="middle">6</td><td align="center" valign="middle">−4.7763</td></tr><tr><td align="center" valign="middle">SMG</td><td align="center" valign="middle">15</td><td align="center" valign="middle">±51</td><td align="center" valign="middle">−42</td><td align="center" valign="middle">36</td><td align="center" valign="middle">−4.4129</td></tr><tr><td colspan="6" align="center" valign="middle" style="border-top:solid thin">PDNF &gt; HCs</td></tr><tr><td align="center" valign="middle">IFG operc</td><td align="center" valign="middle">12</td><td align="center" valign="middle">±54</td><td align="center" valign="middle">15</td><td align="center" valign="middle">12</td><td align="center" valign="middle">−3.6089</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">MFG</td><td align="center" valign="middle" style="border-bottom:solid thin">27</td><td align="center" valign="middle" style="border-bottom:solid thin">±42</td><td align="center" valign="middle" style="border-bottom:solid thin">33</td><td align="center" valign="middle" style="border-bottom:solid thin">36</td><td align="center" valign="middle" style="border-bottom:solid thin">−3.8621</td></tr></tbody></table></div>A corrected threshold of p &lt; 0.01, corrected by Monte Carlo. Anatomical Automatic Labeling 90 was used to report the anatomical regions of our clusters. Abbreviations: HCs: healthy controls, PDF: Parkinson’s disease with fatigue, PDNF: Parkinson’s disease without fatigue, MNI: Montreal Neurological Institute, SMG: supramarginal gyri, IFG operc: opercular parts of inferior frontal gyri, MFG: middle frontal gyri.</transformed-table></extracted-table></extracted-tables-set>